Lv11
60 积分 2025-02-25 加入
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
2小时前
求助中
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
2小时前
已完结
miRNAs modulate altered expression of cytochrome P450s and nicotinic acetylcholine receptor subunits conferring both metabolic and target resistance to sulfoxaflor in Nilaparvata lugens (Stål)
2小时前
已采纳
Efficient removal of direct dyes and heavy metal ion by sodium alginate-based hydrogel microspheres: Equilibrium isotherms, kinetics and regeneration performance study
2小时前
待审核
皖公网安备34019202002308
